NSC |
Compound |
Enrichment |
Correlation |
NSC 743434 |
8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one |
0.0178844438004194 |
0.61677205 |
NSC 746928 |
Null |
0.0178844438004194 |
0.52942397 |
NSC 757113 |
METHOTREXATE(+/-) |
0.0178844438004194 |
0.51781755 |
NSC 112846 |
N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid |
0.0178844438004195 |
0.43891287 |
NSC 301477 |
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- |
0.0178844438004195 |
0.49224557 |
NSC 663337 |
Null |
0.0178844438004195 |
0.6287029 |
NSC 709849 |
Null |
0.0178844438004195 |
0.63270066 |
NSC 730946 |
4-(2-(4-methoxyphenyl)ethynyl)-3-(3,4,5-trimethoxyphenyl)fur an-2(5H)-one |
0.0183522248172065 |
0.35719216 |
NSC 736401 |
Null |
0.0183522248172065 |
0.34060145 |
NSC 750148 |
3-(2-Hydroxy-5-chloro-4-methylphenyl)-5-(2-phenylethene)-1-(4-sulfamylphenyl)-pyrazoline |
0.0183522248172065 |
0.13247365 |